Biosimilars – Market Events And Forecast – Market Event Analysis

Clarivate’s biosimilars experts routinely analyze key market events via a presentation and commentary, available for playback at any time.

Table of contents

  • Biosimilars - Market Events And Forecast - Market Event Analysis
    • Event Analysis
      • Zydus Cadila Launches the Worldu2019s First Trastuzumab Emtansine Biosimilar in India
        • September 2021
      • Fujifilm Kyowa Kirin Biologics and Mylan EPD Launch First Adalimumab Biosimilar in Japan
        • April 2021
      • Henlius / Accord Launch the First MAb Biosimilar Developed in China into the European Market
        • The FDA's New Guidance on Insulin Biosimilar Development
          • December 17, 2019
        • Increasing Insurer Coverage of Biosimilars in the United States
          • August 27, 2019
        • The Future Impact of Authorized Generics on the Biologics Market
          • June 20, 2019
        • The Race for Pegfilgrastim Biosimilars in the United States and Europe
          • September 5, 2018
        • Approval of the First ESA Biosimilar in the United States
          • June 25, 2018
        • Ontruzant's EC Approval
          • April 19, 2018
        • AbbVie Settles with Amgen on Humira Patents
          • October 6, 2017
        • A Step Forward for Oncology Monoclonal Antibody Biosimilars
          • October 2, 2017
        • Coherus's CHS-1701 Rejected by the FDA
          • June 22, 2017
        • The EC Approval of Celltrion's Truxima
          • February 27, 2017
        • FDA Approves the First Etanercept Biosimilar: Sandozu2019s Erelzi
          • September 1, 2016
        • Remaining U.S. Roadblocks to Inflectra Adoption Postapproval
          • May 23, 2016
        • Ten Years of Biosimilars: Insights from the 14th Annual Biosimilar Medicines Group Congress
          • May 19, 2016
        • Highlights from the 8th Biosimilars Congregation
          • March 24, 2016
        • The EMA Approval of Samsung Bioepisu2019s Benepali
          • January 25, 2016

    launch Related Market Assessment Reports